Search research articles
Contact Us
Filters
Showing results (201-210 of 362) with videos related to
Page
of 37
Sort By:
Gastroenterology
|
February 8, 2024
Early Initiation of Biologics and Disease Outcomes in Adults and Children With Inflammatory Bowel Diseases: Results From the Epidemiology Group of the Nationwide Israeli Inflammatory Bowel Disease Research Nucleus Cohort
Rona Lujan, Rachel Buchuk, Gili Focht, et al.
Inflammatory Bowel Diseases
|
April 5, 2024
Durability of the First Biologic in Children and Adults With Ulcerative Colitis: A Nationwide Study from the epi-IIRN
Ohad Atia, Chagit Friss, Gili Focht, et al.
Journal of Crohn'S & Colitis
|
April 29, 2017
Once- Versus Twice-daily Mesalazine to Induce Remission in Paediatric Ulcerative Colitis: A Randomised Controlled Trial
Dan Turner, Baruch Yerushalmi, Michal Kori, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
March 15, 2021
Agreement on Symptoms Between Children With Ulcerative Colitis and Their Caregivers: Towards Developing the TUMMY-UC
Liron Marcovitch, Gili Focht, Anat Horesh, et al.
Journal of Crohn'S & Colitis
|
February 26, 2024
Outcomes in Adult Inflammatory Bowel Disease Clinical Trials: Assessment of Similarity Among Participants with Adolescent-onset and Adult-onset Disease
Joel R Rosh, Dan Turner, Jeffrey S Hyams, et al.
Gastroenterology
|
August 8, 2007
Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study
Dan Turner, Anthony R Otley, David Mack, et al.
Journal of Crohn'S & Colitis
|
April 21, 2023
Association of Antibiotic Use with Durability of Biologic Agents in Inflammatory Bowel Disease: a Report from the epi-IIRN
Yuri Gorelik, Itai Ghersin, Deema Shlon, et al.
Inflammatory Bowel Diseases
|
December 4, 2019
Combination Therapy of Adalimumab With an Immunomodulator Is Not More Effective Than Adalimumab Monotherapy in Children With Crohn's Disease: A Post Hoc Analysis of the PAILOT Randomized Controlled Trial
Manar Matar, Raanan Shamir, Dan Turner, et al.
The Lancet. Gastroenterology & Hepatology
|
January 9, 2025
Maintenance treatment with vedolizumab in paediatric inflammatory bowel disease (VEDOKIDS): 54-week outcomes of a multicentre, prospective, cohort study
Ohad Atia, Zivia Shavit-Brunschwig, Raffi Lev-Tzion, et al.
Current Biology : CB
|
July 7, 2007
Protein-tyrosine phosphatase sigma is associated with ulcerative colitis
Aleixo M Muise, Thomas Walters, Eytan Wine, et al.
Page
of 37
Search research articles
Search
Showing results (201-210 of 362) with videos related to
Sort By:
Page
of 37
Gastroenterology
|
February 8, 2024
Early Initiation of Biologics and Disease Outcomes in Adults and Children With Inflammatory Bowel Diseases: Results From the Epidemiology Group of the Nationwide Israeli Inflammatory Bowel Disease Research Nucleus Cohort
Rona Lujan, Rachel Buchuk, Gili Focht, et al.
Inflammatory Bowel Diseases
|
April 5, 2024
Durability of the First Biologic in Children and Adults With Ulcerative Colitis: A Nationwide Study from the epi-IIRN
Ohad Atia, Chagit Friss, Gili Focht, et al.
Journal of Crohn'S & Colitis
|
April 29, 2017
Once- Versus Twice-daily Mesalazine to Induce Remission in Paediatric Ulcerative Colitis: A Randomised Controlled Trial
Dan Turner, Baruch Yerushalmi, Michal Kori, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
March 15, 2021
Agreement on Symptoms Between Children With Ulcerative Colitis and Their Caregivers: Towards Developing the TUMMY-UC
Liron Marcovitch, Gili Focht, Anat Horesh, et al.
Journal of Crohn'S & Colitis
|
February 26, 2024
Outcomes in Adult Inflammatory Bowel Disease Clinical Trials: Assessment of Similarity Among Participants with Adolescent-onset and Adult-onset Disease
Joel R Rosh, Dan Turner, Jeffrey S Hyams, et al.
Gastroenterology
|
August 8, 2007
Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study
Dan Turner, Anthony R Otley, David Mack, et al.
Journal of Crohn'S & Colitis
|
April 21, 2023
Association of Antibiotic Use with Durability of Biologic Agents in Inflammatory Bowel Disease: a Report from the epi-IIRN
Yuri Gorelik, Itai Ghersin, Deema Shlon, et al.
Inflammatory Bowel Diseases
|
December 4, 2019
Combination Therapy of Adalimumab With an Immunomodulator Is Not More Effective Than Adalimumab Monotherapy in Children With Crohn's Disease: A Post Hoc Analysis of the PAILOT Randomized Controlled Trial
Manar Matar, Raanan Shamir, Dan Turner, et al.
The Lancet. Gastroenterology & Hepatology
|
January 9, 2025
Maintenance treatment with vedolizumab in paediatric inflammatory bowel disease (VEDOKIDS): 54-week outcomes of a multicentre, prospective, cohort study
Ohad Atia, Zivia Shavit-Brunschwig, Raffi Lev-Tzion, et al.
Current Biology : CB
|
July 7, 2007
Protein-tyrosine phosphatase sigma is associated with ulcerative colitis
Aleixo M Muise, Thomas Walters, Eytan Wine, et al.
Page
of 37